Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACT: Donor-derived TCM after HSCT for AML and MDS
NCT02758223Phase 2Completed
- Start
- Apr 2016
- Primary completion
- May 2021
- Countries
- 1
01
Overview
A Phase 2 trial of TCM allogeneic human central memory T cells in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS). Started Apr 2016; status: completed.
02
Drugs
TCM allogeneic human central memory T cells
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT02758223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02758223.